Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease
Dry Eye
About this trial
This is an interventional treatment trial for Dry Eye focused on measuring dry eye, eye spray
Eligibility Criteria
Inclusion Criteria:
- Minimum age 18 years
- OSDI Score of at least 18
- NIBUT smaller or equal to 10s in at least one eye
Exclusion Criteria:
- Post-operative trauma or injury
- Ocular disease with exception of DED
- Hypersensitivity to any of the ingredients in the products used for this study
- Contact lens wear 24h before or on the day of study visits
- Use of eye drops / other eye sprays on the day of visit 1 or during the duration of the study period
Sites / Locations
- Institute of Optometry, FHNW
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ectoin Eye Spray
Liponit Eye Spray
Eye Spray to be applied 3 times per day for the duration of 10 +/-3 days "Ectoin® Eye Spray - Colloidal" (EES09; bitop AG) - CE marked medical device Ingredients: Ectoin®, Soy-Lecithin, Vitamin A, Vitamin E, water, physiological buffer system Indication: to treat mild to moderate dry eye disease
Eye Spray to be applied 3 times per day for the duration of 10 +/-3 days Liposomal eye spray: Tears Again® (TA, Optima Medical Swiss AG) - CE marked medical device Ingredients: Soy-Lecithin, Sodium Chloride, Ethanol, Phenoxyethanol, Vitamin A-Palmitate, Vitamin E, Aqua purificata Indication: to treat mild to moderate dry eye disease